Personalized Approach to Thyroid Disorders Faculty
Register for the ATA 2020 10-Webinar Summer Series as one convenient package or register for each webinar individually.REGISTER NOW
Anne R. Cappola, MD, ScM is a Professor of Medicine in the Division of Endocrinology, Diabetes, and Metabolism, Director of Clinical Research in the Department of Medicine, and Director of the Center for Human Phenomic Science at the Perelman School of Medicine at the University of Pennsylvania. Dr. Cappola directs an NIH-funded research program on the hormonal alterations that occur with aging and the clinical impact of these changes, including the clinical impact of subclinical thyroid dysfunction in older individuals. Dr. Cappola is a highly productive investigator who has published over 100 research publications. Dr. Cappola is an elected member of the American Society for Clinical Investigation, the American Association of Physicians, and the Interurban Clinical Club and an Associate Editor for JAMA. She has received the Thyroid Clinical Research Mentor Award from the Endocrine Society and the American Thyroid Association’s Van Meter Award.
Ramona Dadu, MD is an Assistant Professor in the Department of Endocrine Neoplasia and Hormonal Disorders at The University of Texas M.D. Anderson Cancer Center. She completed her research fellowship at Baylor College of Medicine and the UT Texas M.D. Anderson Cancer Center. She is a member of a number of professional societies including the American Thyroid Association, Endocrine Society, American Association of Clinical Endocrinologists and the American Association of Clinical Oncology. Dr. Dadu is a research grant recipient of the ATA.
Douglas Forrest, PhD is a Senior Investigator at the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health. He was previously an Associate Professor of Human Genetics at Mount Sinai School of Medicine. He received his PhD from Glasgow University. He has dedicated most of his career to research into the developmental and neurodevelopmental functions of thyroid hormone. His interests include the role of thyroid hormone receptors and deiodination in thyroid hormone action. He is a recipient of the Merck Prize of the European Thyroid Association and the Van Meter Award of the ATA. He is an Associate Editor of Endocrinology. He has served on several committees of the ATA including the committee for Trainee and Career Advancement and is a Board member of the American Thyroid Association.
Patrick Ha, MD, FACS is a Professor and the Chief of Head and Neck Oncologic Surgery in the Department of Otolaryngology – Head and Neck Surgery (OHNS) at the University of California, San Francisco. He also holds the Irwin Mark Jacobs and Joan Klein Jacobs Distinguished Professorship in Head and Neck Surgery. After graduating magna cum laude from Harvard University, he received his medical degree from The Johns Hopkins School of Medicine in Baltimore, Maryland. Dr. Ha completed his one-year internship at The Johns Hopkins Hospital, Baltimore, Maryland, and he also completed an otolaryngology residency from the same institution, followed by advanced training in head and neck surgery at The Johns Hopkins Hospital. In addition to his clinical and research work, he serves as the Medical Director for the UCSF Mission Bay Adult Services.
Cari Meinhold Kitahara, PhD, MS is an Investigator in the Division of Cancer Epidemiology and Genetics at the National Cancer Institute, National Institutes of Health. She received an MHS and a PhD in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Kitahara’s research focuses on the etiology of thyroid cancer and on the potential cancer risks associated with occupational and medical radiation exposure. She is Principal Investigator of the U.S. Radiologic Technologists cohort study and the Hyperthyroid Follow-Up Study (an extension of the original Cooperative Thyrotoxicosis Therapy Follow-up Study assembled in the 1960s). She is the 2019 recipient of the Van Meter Award from the American Thyroid Association and serves on the editorial board of Thyroid. She has authored over 120 peer-reviewed manuscripts.
Tim Korevaar, MD, PhD is a postdoctoral fellow at Erasmus University Medical Center in the Netherlands. After a research internship at the Oxford Center for Diabetes, Endocrinology and Metabolism, Dr. Korevaar obtained his MD at the Erasmus University Medical Center. He obtained a PhD at the Erasmus University Medical Center, Academic Center for Thyroid Diseases focusing on ‘thyroid hormone availability during pregnancy and early life: determinants, interpretation and consequences’ (cum laude). His main interest is to translate thyroid physiological aspects into clinically relevant epidemiological studies. His focus has particularly been on determinants of gestational thyroid function (including hCG and endocrine disrupting chemicals) and the risk of adverse pregnancy and child outcomes (including preterm birth and offspring neurocognition). Dr. Korevaar is the recipient of the British Thyroid Award (2014), ECE Young Investigator Award (2016), the Early Career Clinical Lectureship Award (SfE, 2016) and the Early Career Award of the Royal Dutch Academy of Arts and Sciences (2020). He has authored more than 80 peer-reviewed manuscripts and is coordinator of the Consortium on Thyroid and Pregnancy.
Masha J. Livhits, MD is an Assistant Professor of Surgery at the UCLA David Geffen School of Medicine. She attended college at the age of 12 through the highly competitive Early Entrance Program at California State University, Los Angeles. After completing her medical education at Washington University in St. Louis, she obtained her surgical training and Endocrine Surgery fellowship at UCLA. Dr. Livhits has published widely in the area of improving surgical outcomes and quality of care. She is dedicated to combining knowledge learned through research with her experience as a surgeon to deliver the best care to her patients. Her clinical and research interests include parathyroid disease, benign and malignant thyroid tumors, adrenal masses, and familial endocrine disorders. She helped to pioneer the new technique of single incision retroperitoneoscopic adrenalectomy in North America.
Sarah C. Oltmann, MD, FACS attended Baylor University, graduating cum laude for her undergraduate degree. She went on to earn her medical degree at Texas Tech University Health Sciences Center, graduating Alpha Omega Alpha. She completed her general surgery residency at the University of Texas Southwestern Medical Center. She pursued endocrine surgery fellowship training at the University of Wisconsin in Madison, WI. After fellowship, she returned to the University of Texas Southwestern and Parkland Health and Hospital Systems, where she now is the Associate Program Chief of Quality and Best Practice for Parkland Health and Hospital Systems, Medical Director of the General Surgery Clinics, and Director of Endocrine Surgery. Her clinical practice focuses on the surgical management of diseases of the thyroid, parathyroid and adrenal glands. Research interests include management and clinical outcomes in endocrine surgery. She is a previous recipient of the ATA/ThyCa Research Grant for her work on cancer progression and therapeutic response in a mouse model of Medullary Thyroid Cancer. She is happily married, with two sons. She is an avid knitter.
Maria Papaleontiou, MD is an Assistant Professor of Internal Medicine at the University of Michigan, Division of Metabolism, Endocrinology and Diabetes. She is a recipient of Fulbright and Howard Hughes Medical Institute scholarships. She is a health services researcher in the field of aging as it pertains to thyroid disorders, including thyroid cancer. She is particularly interested in overtreatment with and misuse of thyroid hormone and their adverse effects in older adults. She is also involved in studies focusing on thyroid cancer outcomes using large cancer registries and surveys. Dr. Papaleontiou is currently funded by a K08 award from the National Institute on Aging. She is active in the American Thyroid Association, the Endocrine Society and the American Association of Clinical Endocrinologists.
Elizabeth N. Pearce, M.D., M.Sc. is currently a Professor of Medicine at Boston University School of Medicine in the Section of Endocrinology, Diabetes, and Nutrition. She received her undergraduate and medical degrees from Harvard and a masters’ degree in epidemiology from the Boston University School of Public Health. She completed her residency in internal medicine at Beth Israel Deaconess Medical Center, and her fellowship in endocrinology at Boston University. She was the 2018-2019 President of the American Thyroid Association. She also serves as the Regional Coordinator for North America for the Iodine Global Network. She is currently an Associate Editor for Endocrine Practice, Thyroid, and Clinical Thyroidology. She has also served on several other editorial boards, including those for the Journal of Clinical Endocrinology and Metabolism, Clinical Endocrinology, and Lancet Diabetes & Endocrinology. She recently co-chaired the 2017 American Thyroid Association’s Thyroid in Pregnancy Guidelines Task Force. Her research interests include the sufficiency of dietary iodine in the U.S., thyroid function in pregnancy, the thyroid effects of environmental perchlorate exposure, and the cardiovascular effects of subclinical thyroid dysfunction. Dr. Pearce was the 2011 recipient of the American Thyroid Association’s Van Meter Award for outstanding contributions to research on the thyroid gland and the 2018 Women in Thyroidology Woman of the Year.
Susan C. Pitt, MD, MPHS, FACS is an Assistant Professor of Surgery in the Division of Endocrine Surgery at the University of Wisconsin School of Medicine and Public Health. Her clinical practice includes patients with benign and malignant thyroid, parathyroid, and adrenal disease. Dr. Pitt’s NIH funded health services research focuses on reducing overtreatment of patients with thyroid cancer. Her research team investigates the role of emotions, like fear and anxiety, on treatment decision-making. They also utilize stakeholder engagement and have developed two decision support tools for patients with low-risk thyroid cancer. In addition to her medical degree from the Medical College of Wisconsin, Dr. Pitt has a master’s degree in Population Health Science from Washington University in St. Louis with a concentration in shared decision-making. She completed her residency at Washington University in St. Louis followed by an Endocrine Surgery fellowship at Brigham and Women’s Hospital. She holds national leadership positions in the Association of Academic Surgery and the Association of Women Surgeons and is an active member of the American Association of Endocrine Surgeons (AAES) and the American Thyroid Association. She is also a past recipient of the AAES Paul LoGerfo Research Award.
Reese W. Randle, MD, FACS is the Assistant Professor of Surgery at Wake Forest Baptist Medical Center. He obtained his medical degree from the University of Texas Health Science Center, Houston. As a board-certified general surgeon with additional fellowship training in endocrine surgery, he specializes in treating benign and malignant disease of the thyroid, parathyroid, and adrenal glands. Dr. Randle’s clinical research interests have largely focused on improving the quality and efficiency of endocrine surgery and improving the safety of surgical training. He has training in both quantitative and qualitative research methods and employ both in the study of thyroid cancer. He serves on the governing committee for the Collaborative Endocrine Surgery Quality Improvement Program through the American Association of Endocrine Surgeons (AAES) and is the alternate representative for the AAES to the Commission on Cancer.
Jennifer E. Rosen, MD, FACS is Chief of Endocrine Surgery and Vice Chair for Research of the Department of Surgery at Medstar Washington Hospital Center. Dr. Rosen received her undergraduate degree from the University of Pennsylvania and her medical degree from Thomas Jefferson University Medical College. She then completed her residency training in general surgery at Beth Israel Medical Center before completing her fellowship training in surgical oncology at the National Cancer Institute (NCI). Dr. Rosen specializes in the surgical treatment of diseases of the endocrine glands, including the thyroid, parathyroid and adrenal. In addition to surgical techniques, Dr. Rosen works closely with endocrinologists, nuclear medicine physicians and radiologists in order to determine proper testing as well as the best treatment options for each patient. Her clinical interests include treating patients with complex, advanced or recurrent endocrine disease and improving patient outcomes through the use of clinical studies and tailored treatment. Her research interests include bringing in new technology and tools for diagnosing thyroid nodules as well as discriminating cancerous nodules from benign nodules. Dr. Rosen has previously patented tools that are now being used at MedStar Washington Hospital Center. She is currently interested in improving genetic studies in order to predict thyroid cancer in individuals as well as putting together large national databases to look at what improves survival in patients with thyroid cancer. She serves on the Collaborative Endocrine Surgery Quality Improvement Program Committee of the American Association of Endocrine Surgeons (AAES) and sits as a representative of the College to the Commission on Cancer (COC), a program of the American College of Surgeons (ACS). She has been active on numerous committees of the American Thyroid Association (ATA) and serves as Endocrine Section Editor for the Journal of Surgical Oncology.
Mabel M. Ryder, MD is an Endocrinologist and Assistant Professor of Medicine at Mayo Clinic, Rochester. She completed her residency and endocrine fellowship at the University of Cincinnati College of Medicine. Dr. Ryder’s interests are endocrine cancers, thyroid disease and cancer, adrenal disorders and cancer, and the role of tumor microenvironment in facilitating thyroid cancer progressions. She is a member of the American Thyroid Association and International Thyroid Oncology Group.
Jennifer A. Sipos, MD is a Professor of Medicine and Director of the Benign Thyroid Disorders Program at The Ohio State University. She obtained her medical degree and received her Internal Medicine residency training at Wake Forest University. She completed her Endocrinology and Metabolism fellowship at the University of North Carolina in Chapel Hill. Dr. Sipos has developed an interest in the use of ultrasonography for the diagnosis and management of thyroid cancer and has taught and served as a course director for numerous ultrasound courses nationally and internationally, including meetings for the Endocrine Society, American Thyroid Association, European Thyroid Association, American Association for Clinical Endocrinologists, Asia and Oceania Thyroid Association, Indian Endocrine Society, and International Society of Endocrinology. Additionally, she is actively involved in several clinical research projects with a particular interest in factors implicated in the development of salivary damage after radioiodine therapy. She also participates in clinical trials for the evaluation of multikinase inhibitor therapies in refractory thyroid cancer and the diagnostic use of molecular markers in thyroid nodules.
Rebecca S. Sippel, MD, FACS is Professor of Surgery, Chief of the Division of Endocrine Surgery, and Vice Chair of Academic Affairs and Professional Development at the University of Wisconsin. She is a nationally recognized leader in the field of endocrine surgery. She is currently serving as the program director for the Endocrine Surgery Fellowship at the University of Wisconsin. She is past Secretary of the American Association of Endocrine Surgeons and past President of Association for Academic Surgery. She has a highly productive clinical research program focusing on the diagnosis and management of patients with endocrine disorders and the outcomes of patients after surgery. She is currently PI on an R01 funded randomized controlled trial examining the utility of prophylactic central neck dissection for patients with clinically node negative thyroid cancer.